Abstract 291P
Background
Malnutrition is one of the most frequent disorders in cancer patients which accounts for 50-90%. This high prevalence of malnutrition is very concerning as it is associated with reduced treatment efficacy, functional status, quality of life and survival. The prevalence of malnutrition varies with tumor type, site and the stage of the disease. The highest prevalence of cancer patients with nutritional deficits is seen in those with tumors of the gastrointestinal tract and lung.
Methods
It is a hospital based cross sectional study among 95 cancer patients. They were screened using Patient Generated Subjective Global Assessment (PGSGA) for malnutrition. Median and IQR were used to describe the continuous data and frequency and percentage for the categorical variables. To identify the correlation between continuous variables, Pearson’s correlation coefficient was used. At 95% confidence interval, p value less than 0.05 was termed as statistically significant. The data were analyzed using SPSS 20.0 software.
Results
Among 95 patients, 36.85% of patients were GI cancers followed by 27.37% lung cancer, breast cancer (10.53%) and rectal cancer (10.53%). Most of the patients (81.05%) were well nourished Subjective Global Assessment (SGA-A), 13.68% patients were moderately malnourished or had suspected malnutrition (SGA-B) and 5.26% patients were severely malnourished (SGA-C). There was statistically significant difference in association of malnutrition with gastrointestinal cancer. Among equally distributed limited and metastatic cancers, there was no significant association between stages of cancer with malnutrition.
Conclusions
Nutritional assessment and support should be an integral part of care in gastrointestinal cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
293P - Generic dabigatran for cancer-associated venous thromboembolism: Real-world data
Presenter: Fen Saj
Session: Poster viewing 04
294P - Cross-sectional analysis on cancer-related distress, belief in alternative medicine among cancer patients and attendants visiting a tertiary care center in Northern India
Presenter: Amit Sehrawat
Session: Poster viewing 04
296P - Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA
Presenter: Yi-Long Wu
Session: Poster viewing 04
297P - Transbronchial microwave ablation of early lung cancers and lung oligometastases: Mid-term results
Presenter: Joyce Chan
Session: Poster viewing 04
298P - Does trisegmentectomy have functional benefit over lobectomy? Comparative analysis of changes in lung function and volumetry among stage IA non-small cell lung cancer patients
Presenter: sumin shin
Session: Poster viewing 04
299P - Furmonertinib as adjuvant therapy in EGFR-mutated non-small cell lung cancer following radical lung cancer surgery
Presenter: Qingyi Zhang
Session: Poster viewing 04
300P - Real-world efficacy and safety of anlotinib in combination with PD-1/PD-L1 inhibitors as first-line or second-line treatment in advanced non-small cell lung cancer
Presenter: Xin Shang
Session: Poster viewing 04
301P - Oxygen desaturation during 6-min walk test: Implications for postoperative complications in non-small cell lung cancer patients with impaired lung function
Presenter: Hye Yun Park
Session: Poster viewing 04
302P - Treatment patterns in resectable early-stage NSCLC in Taiwan: Subgroup analysis of a global real-world study
Presenter: Jin-Yuan Shih
Session: Poster viewing 04